TRAF6 and Insulin resistance: The reduced level of miR-124 could promote progression to T2DM through interactions with NF-κB, TRAF-6, and cytokines (TNFα and IL-6), which lead to insulin resistance, poor glycemic control, and a pro-inflammatory state [41,42].